Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds

Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and affects over 6 million people worldwide. Development of new drugs to treat this disease remains a priority since those currently available have variable efficacy and frequent adverse effects, especially during the long regimens...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Peinado, Nieves, Martori, Clara, Cortes-Serra, Nuria, Sherman, Julian, Rodriguez, Ana, Gascon, Joaquim, Alberola, Jordi, Pinazo, Maria-Jesus, Rodriguez-Cortes, Alheli, Alonso-Padilla, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828178/
https://www.ncbi.nlm.nih.gov/pubmed/33445756
http://dx.doi.org/10.3390/ijms22020688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828178/
https://www.ncbi.nlm.nih.gov/pubmed/33445756
http://dx.doi.org/10.3390/ijms22020688

Ejemplares similares